Arthur Branstrom

PTC124 targets genetic disorders caused by nonsense mutations

Ellen Welch, Elisabeth R. Barton, Jin Zhuo et al. · Nature · 2007 · 1.1K citations

Mendelian Disorder, Genetic Disorder, Genetics +4

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

Eitan Kerem, Michael W. Konstan, K. De Boeck et al. · The Lancet Respiratory Medicine · 2014 · 333 citations · Full text

Allergy, Placebo-controlled Phase 3, Clinical Trials +3

Attenuated <i>Shigella</i> as a DNA Delivery Vehicle for DNA-Mediated Immunization

Donata Sizemore, Arthur Branstrom, Jerald Sadoff · Science · 1995 · 288 citations

Vaccination, Mucosal Vaccination, Dna Nanotechnology +15

Genetic Basis for Activity Differences Between Vancomycin and Glycolipid Derivatives of Vancomycin

Ulrike Eggert, Natividad Ruiz, Brian V. Falcone et al. · Science · 2001 · 138 citations

Glycobiology, Antimicrobial Chemotherapy, Drug Resistance +17

The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells

Yuichiro Nishida, Aya Maeda, M J Kim et al. · Blood Cancer Journal · 2017 · 103 citations · Full text